Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
Research output: Contribution to journal › Article › peer-review
28Scopus
citations
Fingerprint
Dive into the research topics of 'Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice'. Together they form a unique fingerprint.